Stop TB Partnership

Joining forces with private practitioners in a unique partnership against drug-resistant TB in Chennai, India


11 November 2015 - The fight for a TB-free India continues to gain ground with the launch of an innovative project in the city of Chennai. Through a public-private partnership project EQUIP, patients visiting private health practitioners can now be offered rapid, accurate diagnosis for TB and multidrug-resistant TB. The Lilly MDR-TB Partnership, KNCV Tuberculosis Foundation, and local non-governmental organization REACH (Resource Group for Education and Advocacy for Community Health) are joining forces with India’s TB control program (RNTCP) in this unique collaboration.

EQUIP seeks to demonstrate that the private sector in India can be a big part of the solution for a TB-Free India. Through EQUIP, private sector health providers and their patients have free access to the new GeneXpert laboratory test for early diagnosis of TB and the detection of TB drug-resistance. This means that we can save more lives and prevent others from becoming infected. Read more

Photo: EQUIP project REACH Chennai lab staff PPM center Hindu Welfare Hospital in Central Chennai